This application seeks continuing support for the 5 year period 7/96-6/01 of a NIH predoctoral training program directed at providing a cross- disciplinary educational experience in biotechnology. The Stanford program has been in existence since 7/91 and is funded through 6/96. It draws on a faculty group from 10 units and 3 Schools at the University. These units include within the School of Engineering: Chemical and Civil Engineering; within the School of Humanities and Sciences: Chemistry and Biological Sciences; and within the School of Medicine: Cell Biology, Genetics, Neurobiology, Molecular Pharmacology, Developmental Biology, and Biochemistry. The 26 faculty involved in the training program have the common goal of providing a multidisciplinary framework for exposing predoctoral students to a broad cross-section of the theoretical, experimental and computational components of biotechnology. Trainees selected for this program are among those graduate students already admitted by each of the units following their usual admissions procedures. In addition to meeting the Ph.D. requirements for their primary unit, each trainee is required to participate in a biotechnology seminar series, in seminars on biomedical ethics, in a journal club, in an annual industrial biotechnology symposium and to complete a four quarter graduate-level course requirement encompassing biochemistry, genetics, and biotechnology. These activities are designed to provide a common basis for the trainees and to give then a forum for interacting in groups that extend beyond their focused research activities. The trainees are required to have two or more of the participating faculty as members of their dissertation reading committees. These committees are formed early in the tenure of the trainee and operate to insure the dissemination of information and expertise to the trainee by preceptors from different basic science and engineering areas relate to biotechnology. Local biotechnology industries in the San Francisco Bay Area provide intellectual and physical resources to the trainees and thereby offer an opportunity for the students to access the talent that surrounds the University. In some instances, trainees may be co-advised by industrial mentors and will perform some of their research offsite at facilities made available by the industrial participants. In addition, internships, typically three months in duration, are offered to trainees in those cases where there is sufficient mutual interest between the university research efforts and the industrial counterpart to warrant such an arrangement. An annual Industrial Biotechnology Symposium is held each Spring to introduce and expose the trainees to the science and engineering being conducted in the local biotechnology industrial sector. The primary goal of the program is to have the trainees become proficient in a variety of physical, chemical, biological and computational research techniques and to provide a learning environment that cuts across the boundaries of several disciplines that are major contributors to the biotechnology enterprise. In so doing, our trainees become prepared for careers in biotechnology at both the industrial and university levels.

Agency
National Institute of Health (NIH)
Institute
National Institute of General Medical Sciences (NIGMS)
Type
Institutional National Research Service Award (T32)
Project #
5T32GM008412-10
Application #
6150887
Study Section
Special Emphasis Panel (ZGM1-BT-5)
Program Officer
Jones, Warren
Project Start
1991-07-01
Project End
2001-06-30
Budget Start
2000-07-01
Budget End
2001-06-30
Support Year
10
Fiscal Year
2000
Total Cost
$348,885
Indirect Cost
Name
Stanford University
Department
Engineering (All Types)
Type
Schools of Engineering
DUNS #
800771545
City
Stanford
State
CA
Country
United States
Zip Code
94305
Toda, Satoshi; Blauch, Lucas R; Tang, Sindy K Y et al. (2018) Programming self-organizing multicellular structures with synthetic cell-cell signaling. Science 361:156-162
Mitchell, Aaron C; Alford, Spencer C; Hunter, Sean A et al. (2018) Development of a Protease Biosensor Based on a Dimerization-Dependent Red Fluorescent Protein. ACS Chem Biol 13:66-72
Mitchell, Aaron C; Kannan, Deepti; Hunter, Sean A et al. (2018) Engineering a potent inhibitor of matriptase from the natural hepatocyte growth factor activator inhibitor type-1 (HAI-1) protein. J Biol Chem 293:4969-4980
Blauch, Lucas R; Gai, Ya; Khor, Jian Wei et al. (2017) Microfluidic guillotine for single-cell wound repair studies. Proc Natl Acad Sci U S A 114:7283-7288
Ly, Nina; Cyert, Martha S (2017) Calcineurin, the Ca2+-dependent phosphatase, regulates Rga2, a Cdc42 GTPase-activating protein, to modulate pheromone signaling. Mol Biol Cell 28:576-586
Steele, Amanda N; Cai, Lei; Truong, Vi N et al. (2017) A novel protein-engineered hepatocyte growth factor analog released via a shear-thinning injectable hydrogel enhances post-infarction ventricular function. Biotechnol Bioeng 114:2379-2389
Bisaria, Namita; Greenfeld, Max; Limouse, Charles et al. (2017) Quantitative tests of a reconstitution model for RNA folding thermodynamics and kinetics. Proc Natl Acad Sci U S A 114:E7688-E7696
Kariolis, Mihalis S; Miao, Yu Rebecca; Diep, Anh et al. (2017) Inhibition of the GAS6/AXL pathway augments the efficacy of chemotherapies. J Clin Invest 127:183-198
Hahn, Aria S; Altman, Tomer; Konwar, Kishori M et al. (2017) A geographically-diverse collection of 418 human gut microbiome pathway genome databases. Sci Data 4:170035
Suarez, Sophia L; Muñoz, Adam; Mitchell, Aaron et al. (2016) Degradable acetalated dextran microparticles for tunable release of an engineered hepatocyte growth factor fragment. ACS Biomater Sci Eng 2:197-204

Showing the most recent 10 out of 45 publications